Dihydrotestosterone and the prostate: The scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia

Gerald Andriole, Nicholas Bruchovsky, Leland W K Chung, Alvin M. Matsumoto, Roger Rittmaster, Claus Roehrborn, David W Russell, Donald Tindall

Research output: Contribution to journalArticlepeer-review

233 Scopus citations

Fingerprint

Dive into the research topics of 'Dihydrotestosterone and the prostate: The scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences